Atara Biotherapeutics, Inc. (ATRA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 0.5458 |
| Open | 0.5700 |
| Bid | 0.5250 x 200 |
| Ask | 0.5665 x 1100 |
| Day's Range | 0.5250 - 0.6242 |
| 52 Week Range | 0.1990 - 2.5350 |
| Volume | |
| Avg. Volume | 1,676,645 |
| Market Cap | 65.699M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Atara Biotherapeutics (ATRA) Reports Q1 Loss, Tops Revenue Estimates
Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of 37.84% and 1.32%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Atara Biotherapeutics (ATRA) Reports Q4 Loss, Tops Revenue Estimates
Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of 8.20% and 73.91%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
After losing 76% in the past year, Atara Biotherapeutics, Inc. (NASDAQ:ATRA) institutional owners must be relieved by the recent gain
Key Insights Institutions' substantial holdings in Atara Biotherapeutics implies that they have significant influence...
© 2024 Yahoo. All rights reserved.